Wednesday, October 7, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 4, 2026

Dell and Dream Finders Homes have been highlighted as Zacks Bull and Bear of the Day

View original at finance.yahoo.com
Dell and Dream Finders Homes have been highlighted as Zacks Bull and Bear of the Day For Immediate Release Chicago, IL – June 4, 2026 – Zacks Equity Research shares Dell Technologies DELL as the Bull of the Day and The Campbell's Company CPB as the Bear of the Day…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Analysts have upwardly adjusted their sales expectations for Dell's current and next fiscal years following the earnings release.

    60% confidence

  • The AI opportunity shows no signs of slowing.

    60% confidence

  • Dell Technologies is rated Zacks Rank #1 (Strong Buy) with EPS revisions remaining bullish across the board.

    60% confidence

  • The Campbell's Company is rated Zacks Rank #5 (Strong Sell) with EPS revisions remaining bearish across the board.

    60% confidence

  • Dell AI-optimized servers achieved 760% YoY growth, setting a company record.

    60% confidence

  • CPB shares have continued to see weak action in 2026 and quarterly results have been largely disappointing, with shares facing pressure following its latest earnings release.

    60% confidence

  • Dell Technologies exceeded the Zacks Consensus EPS estimate by nearly 60% and posted a 23% sales surprise.

    60% confidence

  • Dell Technologies would be an excellent stock for investors to consider given its Zacks Rank #1 (Strong Buy).

    60% confidence

Data points we hold from this source

Dell Technologies · stock price230 percent_ytd_return
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,351 source documents archived
Query this data → isubstrate.com
Dell and Dream Finders Homes have been highlighted as Zacks Bull and Bear of the Day — Source | Via News | ViaNews Market